Results 201 to 210 of about 136,755 (290)

Acoustic Sensing as a Tool for Brain Tumor Diagnostics

open access: yesAdvanced Sensor Research, Volume 5, Issue 2, February 2026.
Surface acoustic wave (SAW) sensing is used to distinguish non‐neoplastic brain tissue from primary and metastatic tumors based on their acoustic attenuation signatures. Ex vivo human brain samples reveal clear tissue‐specific mechanical profiles, correlating with stiffness and malignancy.
Melanie E. M. Stamp   +6 more
wiley   +1 more source

TTF-1, CDX-2, PAX-8 and GATA-3 immunoexpression in a large serie of extrapulmonary small cell neuroendocrine carcinomas: a study of 138 cases. [PDF]

open access: yesDiagn Pathol
Pavlíčková K   +12 more
europepmc   +1 more source

Esketamine/Ketamine: Dual‐Action Mechanisms and Clinical Prospects beyond Anesthesia in Psychiatry, Immunology, and Oncology

open access: yesAdvanced Science, Volume 13, Issue 7, 3 February 2026.
Esketamine and ketamine are widely used for perioperative analgesia and anesthesia. Despite their established roles in analgesia, sedation, and anesthesia, as well as emerging antidepressant, anti‐tumor, and anti‐inflammatory effects, their clinical use is limited due to side effects and addiction potential.
Yinxin Wang   +7 more
wiley   +1 more source

A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Hepatoid adenocarcinoma (HAC) is a rare extrahepatic tumor of non‐germ cell origin that morphologically resembles hepatocellular carcinoma (HCC). HAC has a propensity to metastasize to the liver and therefore may be mistaken for HCC. There is a lack of standardized treatment protocols, and further studies are needed to evaluate the benefit of ...
Christina Liava   +4 more
wiley   +1 more source

Molecular Landscape of TP53/RB1 Co-Altered Tumors Uncovers Emerging Therapeutic Vulnerabilities. [PDF]

open access: yesGenes Chromosomes Cancer
Li X   +8 more
europepmc   +1 more source

Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population‐Based Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Aims Clear cell adenocarcinoma of the cervix (CCAC) is a rare and aggressive malignancy with poor prognosis. This study aimed to develop and validate nomograms and risk‐stratification scores for predicting overall survival (OS) and cancer‐specific survival (CSS) in CCAC patients.
Lijun Chen   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy